Welcome to our dedicated page for Elevra Lithium SEC filings (Ticker: ELVR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Elevra Lithium's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Elevra Lithium's regulatory disclosures and financial reporting.
Elevra Lithium Ltd (ELVR) reports two strategic developments. First, it signed an indicative, non-binding term sheet with Morella Corporation to expand their Western Australia exploration joint venture. Four Elevra projects will be added, with Morella able to earn a 51% interest by funding A$300,000 of exploration in two years, leaving Elevra with 49%. Morella will operate and fund exploration during the earn-in, while Elevra retains legal title and a 49% ongoing stake if the earn-in is completed.
Second, Elevra executed a binding Spodumene Concentrate Supply Agreement with Mangrove Lithium for production from North American Lithium in Québec. The contract has an initial 7‑year term plus a potential 7‑year renewal and take‑or‑pay volumes of 122,000 dmt in year 1 and 144,000 dmt annually from year 2, with Mangrove able to increase volumes by up to 20% subject to NAL capacity. Pricing is market‑linked with a floor that management expects to be above NAL’s cost of production and no price ceiling, preserving upside. Deliveries to an Eastern Canada facility are expected to avoid seaborne freight costs, and both Elevra and Mangrove have secured support from the Canada Growth Fund for their respective projects.
Elevra Lithium Ltd (ELVR) reports as a foreign private issuer and has announced timing for its FY26 financial results and annual report. The company plans to release these materials on Friday, 28 August 2026.
Elevra will host an investor webcast covering the FY26 financial results, commencing at 9:30 a.m. AEST on 28 August 2026 (which corresponds to 7:30 p.m. EDT on 27 August 2026). Investors can access the live and archived webcast via a registration link and through the Elevra website.
Van Eck Associates Corporation reported beneficial ownership of 12,400,490 Elevra Lithium Limited American Depositary Shares, representing 6.4% of this class. Van Eck has sole voting and sole dispositive power over all reported shares, with no shared voting or dispositive authority.
Elevra Lithium Limited has completed the sale of all its rights, interests and obligations on exploration tenement E45/2364 in Western Australia (Tabba Tabba) to Wildcat Resources Limited. Under the agreement, Wildcat assumes full ownership, control and liability for these rights.
Elevra will receive total consideration of $16 million plus an ongoing royalty if Wildcat defines a Pegmatite Mineral Resource on E45/2364. This mix of guaranteed and contingent payments provides immediate value from a non-core asset while preserving upside exposure. Elevra states that the transaction aligns with its strategy to focus capital on its core North American lithium assets, including the NAL Brownfield Expansion and its development pipeline.
North American lithium producer Elevra Lithium Limited has issued a C$65 million Upfront Tranche of Convertible Notes to a subsidiary of Canada Growth Fund Inc. under a previously announced strategic financing package, following shareholder approval at an extraordinary general meeting on 16 July 2026.
The notes mature five years from their 31 July 2026 issue date, accrue interest at CORRA floored at zero plus 2.25% per annum, payable semi-annually, and are convertible into Elevra ordinary shares at A$17.17 per share from the first anniversary until shortly before maturity. Proceeds are intended to fund the staged expansion of the North American Lithium brownfield project and provide additional liquidity for capital management. A further C$80 million Conditional Tranche of Convertible Notes remains subject to shareholder approval, Elevra’s election to draw, and other customary conditions. Following this issue, 65,000,000 unquoted Convertible Notes are on issue alongside 194,016,029 quoted ordinary shares.
Elevra Lithium Limited delivered higher production at its North American Lithium operation in the June 2026 quarter while restructuring its balance sheet to fund growth. Spodumene concentrate output rose to 54,479 dmt at 71% recovery, supported by strong mill utilisation and improved feed grades. However, NAL revenue fell to US$31 million, driven by a 39% drop in tonnes sold and a 37% lower average realised price of US$921/dmt under a legacy offtake contract that is now fully satisfied, with future sales expected to track spot pricing more closely.
Group cash and cash equivalents increased to US$255 million (net cash US$200 million), aided by a Strategic Financing Package consisting of a fully underwritten US$196 million institutional placement, US$102 million in Convertible Notes from Canada Growth Fund and an additional US$11 million raised via a Share Purchase Plan. An Updated Scoping Study for the staged NAL Brownfield Expansion outlined an incremental post-tax NPV of C$969 million, with the new funding expected to fully finance the expansion and advance the Moblan project toward a Final Investment Decision. Elevra also agreed to sell its Ewoyaa Project interest for approximately US$71 million in cash, sharpening its focus on its North American portfolio.
Elevra Limited, a North American lithium producer, plans to release its June 2026 Quarterly Activities Report on 28 July 2026. The company will host an investor webcast covering the results at 9:30am AEST (7:30pm EDT on 27 July 2026), with live and archived access via its website.
Elevra Lithium Limited outlines a three-stage expansion of its North American Lithium (NAL) operation and reports strong shareholder backing at the 2026 Extraordinary General Meeting. Shareholders approved resolutions to ratify a prior institutional placement of 22,540,984 shares, approve Tranche 1 convertible notes to LCSC Holdings Inc. (Canada Growth Fund), ratify shares and options issued to Lithium Offtake Inc., and approve financial assistance under section 260B of the Corporations Act, all with voting support of about 99.7% on polls.
The company presents a phased debottlenecking and capacity expansion at NAL, targeting 4,500 tonnes per day in Stage 1 by mid‑CY2027, 6,500 tonnes per day in Stage 2 by CY2028 and a full crushing circuit upgrade in CY2029. An updated scoping study indicates annual spodumene concentrate capacity increasing from 194ktpa to about 338ktpa, a rise of approximately 74%, while average life‑of‑mine C1 costs are expected to fall by around 21%. The same study shows NAL’s post‑tax 8% NPV rising from US$1,587M to US$2,305M.
To fund this growth, Elevra has arranged a strategic financing package totalling A$508M, comprising a fully underwritten A$275M equity placement, A$146M of convertible notes from Canada Growth Fund and expected net proceeds of about A$87M from the agreed sale of its Ewoyaa Project interest. The company states this package fully funds the NAL expansion under current market conditions and also supports pre‑development work at the Moblan project. The Canada Growth Fund notes, issued in two tranches, include an upfront A$65M tranche convertible at A$17.17 per share and a conditional A$81M tranche convertible at a 30% premium to a future VWAP, which Elevra highlights as helping limit dilution while aligning capital deployment with project milestones.
Elevra Lithium Limited reported a June 2026 quarter production update for its North American Lithium operation in Québec and disclosed a small equity incentive issuance. NAL produced approximately 54,479 dmt of spodumene concentrate and sold about 33,977 dmt, at an average realised provisional price of US$919 per dmt FOB. Production rose 15% from the March 2026 quarter, with May output of roughly 22,202 dmt and full‑year production of about 197,968 dmt. Inventory at quarter‑end was around 40,863 dmt, with lower realised pricing driven by contractual lagged pricing based on October 2025–March 2026 market levels. Elevra also issued 2,160 unquoted performance rights under an employee incentive scheme, bringing ordinary shares on issue to 194,016,029 and performance rights to 2,660,336.
Elevra Limited is updating investors on recent changes to its share and incentive capital reported to the ASX and furnished on a Form 6-K. The company confirms that 49,990 ELVAM performance rights lapsed on 30 June 2026 because vesting conditions were not met. Separately, 200,524 ELVAM performance rights under an employee incentive scheme converted into ELV ordinary fully paid shares between 3 March 2026 and 30 June 2026 via a transfer of existing shares. After these changes, the ASX tables show 194,016,029 ELV ordinary shares on issue and a reduced pool of unquoted ELVAM performance rights alongside existing options.